The Nasdaq Biotechnology Index rose by 1.11%. Among the constituent stocks, Prime Medicine increased by 10.46%, while Amylyx Pharmaceuticals, Lexicon Pharma, Kyverna Therapeutics, and Foghorn rose by 9.51% to 8.89%. In contrast, Amarin fell by 5.08%, Alpha Teknova dropped by 6.65%, and Q32 Bio saw a significant decline of 23.68%
The Nasdaq Biotechnology Index closed up 1.11%. Component stock Prime Medicine rose 10.46%, while Amylyx Pharmaceuticals, Lexicon Pharma, Kyverna Therapeutics, and Foghorn rose between 9.51% and 8.89%. Amarin, on the other hand, fell 5.08%, Alpha Teknova dropped 6.65%, and Q32 Bio decreased by 23.68%